NCT04391647View on ClinicalTrials.gov

Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Human Papilloma Virus Infection
Interventions
OTHER

First-void urine collection

"* One time collection of ca. 20 ml of first-void urine with the Colli-PeeTM device (Novosanis) during visit at the Centre for the Evaluation of Vaccination.~* IF HPV positive and the woman gave consent to be contacted again: Collection of ca. 20 ml of first-void urine with the Colli-PeeTM device (Novosanis) each day during 14 days (n = 14)"

OTHER

Blood draw

\- One time blood sample collection (5-10 cc) by a study nurse of Centre for the Evaluation of Vaccination.

Trial Locations (1)

2610

Universiteit Antwerpen, Antwerp

All Listed Sponsors
lead

Universiteit Antwerpen

OTHER

NCT04391647 - Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples | Biotech Hunter | Biotech Hunter